Three Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting NSCLC

Three Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting NSCLC

Background/Aims: Circulating long non coding RNAs (lncRNAs) have emerged recently as major players in tumor biology and may be used for cancer diagnosis, prognosis, and as potential therapeutic targets. We explored circulating lncRNA as a predictor for the tumorigenesis of non-small-cell lung cancer...

Full description

Bibliographic Details
Main Authors:	Qingfeng Tang, Zhenhua Ni, Zhuoan Cheng, Jianhua Xu, Hui Yu, Peihao Yin
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2015-09-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Circulation ROC curve Risk score analysis NSCLC
Online Access:	http://www.karger.com/Article/FullText/430226

Similar Items

Circulating CircRNAs Panel Acts as a Biomarker for the Early Diagnosis and Severity of Parkinson’s Disease
by: Lingling Zhong, et al.
Published: (2021-07-01)

Circulating Long Noncoding RNAs as Biomarkers for Predicting Head and Neck Squamous Cell Carcinoma
by: Yao Yao, et al.
Published: (2018-10-01)

A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer
by: Maha M. Itani, et al.
Published: (2021-06-01)

Circulating plasma microRNAs as diagnostic markers for NSCLC
by: Jinpao Hou
Published: (2016-11-01)

Establishment and Characterization of an Empirical Biomarker SS/PV-ROC Plot Using Results of the UBC<sup>®</sup> <i>Rapid</i> Test in Bladder Cancer
by: Peter Oehr, et al.
Published: (2020-06-01)

Evaluation of Probability of Survival using APACHE II & TRISS Method in Orthopaedic Polytrauma Patients in a Tertiary Care Centre
by: Archit Agarwal, et al.
Published: (2015-07-01)

A risk score development for diabetic retinopathy screening in Isfahan-Iran
by: Sayed Mohsen Hosseini, et al.
Published: (2009-04-01)

Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment
by: Po‐Lan Su, et al.
Published: (2019-10-01)

Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma
by: Hai-bo Hu, et al.
Published: (2016-11-01)

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
by: Edoardo Lenci, et al.
Published: (2021-03-01)

Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
by: Melanie Janning, et al.
Published: (2019-06-01)

Conception d’un outil simple d'utilisation pour réaliser des analyses statistiques ajustées valorisant les données de cohortes observationnelles de pathologies chroniques : application à la cohorte DIVAT
by: Le Borgne, Florent
Published: (2016)

Application of Bézier Curves for Calculating Likelihood Ratios for Plasma Amyloid-β Biomarkers for Alzheimer's Disease
by: Walter Fierz
Published: (2018-10-01)

Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
by: Jen-Tai Lin, et al.
Published: (2021-04-01)

Cut-off scores for the Minimal Eating Observation and Nutrition Form – Version II (MEONF-II) among hospital inpatients
by: Peter Hagell, et al.
Published: (2011-07-01)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
by: Umberto Malapelle, et al.
Published: (2021-05-01)

Çarpık dağılımlı verilerde ROC eğrisi altında kalan alan tahmininde transformasyon etkili mi?
by: İlker ÜNAL
Published: (2018-03-01)

A 3-circular RNA signature as a noninvasive biomarker for diagnosis of colorectal cancer
by: Dao-xiong Ye, et al.
Published: (2019-11-01)

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
by: Simona Coco, et al.
Published: (2017-05-01)

Lognormal Lorenz and normal receiver operating characteristic curves as mirror images
by: R. John Irwin, et al.
Published: (2015-01-01)

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
by: Yimin Yang, et al.
Published: (2021-03-01)

Circulating MicroRNAs: Potential Biomarkers for Cancer
by: Yi-Tao Ding, et al.
Published: (2011-03-01)

Utilidad de la escala clínica de Rockall en la hemorragia digestiva alta no varicosa
by: Mirtha Infante Velázquez, et al.

Methods for Designing and Forming Predictive Genetic Tests
by: Lu, Qing
Published: (2008)

Post-Surgery Circulating Tumor Cells and <i>AXL</i> Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
by: Diego de Miguel-Pérez, et al.
Published: (2019-11-01)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
by: Giustini N, et al.
Published: (2021-03-01)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
by: Zhang M, et al.
Published: (2021-01-01)

Use of fecal and serologic biomarkers in the prediction clinical outcomes in children presenting with abdominal pain and/or diarrhea
by: Rogerson, Sara M.
Published: (2017)

Evaluation statistique des outils diagnostiques et pronostiques à l'aide des surfaces ROC
by: Nze Ossima, Arnaud Davin
Published: (2014)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
by: Zhang M, et al.
Published: (2021-02-01)

Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma
by: Sutpirat Moonmuang, et al.
Published: (2021-08-01)

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
by: Rui Fang, et al.
Published: (2018-11-01)

Time Spent Sitting Is Associated with Changes in Biomarkers of Frailty in Hospitalized Older Adults: A Cross Sectional Study
by: Jair S. Virtuoso Júnior, et al.
Published: (2017-07-01)

Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
by: Chara Papadaki, et al.
Published: (2020-05-01)

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer
by: Alexia Monastirioti, et al.
Published: (2021-08-01)

Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC
by: Vera Kloten, et al.
Published: (2019-08-01)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
by: Óscar Rapado-González, et al.
Published: (2019-06-01)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
by: Joanna Kapeleris, et al.
Published: (2018-08-01)

Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
by: Alice Indini, et al.
Published: (2021-04-01)

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
by: Xiaohong Xie, et al.
Published: (2021-05-01)